Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma

BACKGROUND AND AIMS: Assessing treatment responses in hepatocellular carcinoma (HCC) is challenging, and alternative radiologic methods of measuring treatment response are required. Modified Response Evaluation Criteria in Solid Tumors (mRECIST) for HCC and alpha-fetoprotein (AFP) levels were assess...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Liver Cancer
Main Authors: Raoul, Jean-Luc, Park, Joong-Won, Kang, Yoon-Koo, Finn, Richard S, Kim, Jun Suk, Yeo, Winnie, Polite, Blasé N, Chao, Yee, Walters, Ian, Baudelet, Christine, Lencioni, Riccardo
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2014
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4531422/
https://ncbi.nlm.nih.gov/pubmed/26280005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000343872
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados